JP2005501508A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501508A5
JP2005501508A5 JP2002556615A JP2002556615A JP2005501508A5 JP 2005501508 A5 JP2005501508 A5 JP 2005501508A5 JP 2002556615 A JP2002556615 A JP 2002556615A JP 2002556615 A JP2002556615 A JP 2002556615A JP 2005501508 A5 JP2005501508 A5 JP 2005501508A5
Authority
JP
Japan
Prior art keywords
ala
gln
seq
gly
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002556615A
Other languages
English (en)
Japanese (ja)
Other versions
JP4029041B2 (ja
JP2005501508A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/000869 external-priority patent/WO2002055547A2/en
Publication of JP2005501508A publication Critical patent/JP2005501508A/ja
Publication of JP2005501508A5 publication Critical patent/JP2005501508A5/ja
Application granted granted Critical
Publication of JP4029041B2 publication Critical patent/JP4029041B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002556615A 2001-01-10 2002-01-10 ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法 Expired - Lifetime JP4029041B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26090801P 2001-01-10 2001-01-10
PCT/US2002/000869 WO2002055547A2 (en) 2001-01-10 2002-01-10 Sfrp and peptide motifs that interact with sfrp and methods of their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007120533A Division JP4248583B2 (ja) 2001-01-10 2007-05-01 ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法

Publications (3)

Publication Number Publication Date
JP2005501508A JP2005501508A (ja) 2005-01-20
JP2005501508A5 true JP2005501508A5 (enExample) 2005-09-02
JP4029041B2 JP4029041B2 (ja) 2008-01-09

Family

ID=22991151

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002556615A Expired - Lifetime JP4029041B2 (ja) 2001-01-10 2002-01-10 ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法
JP2007120533A Expired - Lifetime JP4248583B2 (ja) 2001-01-10 2007-05-01 ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法
JP2008169716A Expired - Lifetime JP4248600B2 (ja) 2001-01-10 2008-06-30 ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007120533A Expired - Lifetime JP4248583B2 (ja) 2001-01-10 2007-05-01 ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法
JP2008169716A Expired - Lifetime JP4248600B2 (ja) 2001-01-10 2008-06-30 ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法

Country Status (11)

Country Link
US (2) US7488710B2 (enExample)
EP (1) EP1387854B1 (enExample)
JP (3) JP4029041B2 (enExample)
AT (1) ATE550345T1 (enExample)
AU (1) AU2002241859B2 (enExample)
CA (1) CA2434672C (enExample)
CY (1) CY1112875T1 (enExample)
DK (1) DK1387854T3 (enExample)
ES (1) ES2385666T3 (enExample)
PT (1) PT1387854E (enExample)
WO (1) WO2002055547A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1731908B1 (en) * 2004-03-31 2010-09-01 Kazuo Shinya Method of biosubstance trapping, structural analysis or/and identification with use of a labeling substance
KR20070102684A (ko) * 2004-12-23 2007-10-19 몰메드 에스피에이 접합 생성물
WO2008061029A1 (en) * 2006-11-10 2008-05-22 Wyeth Aryl sulfonamide derivatives and methods of their use
MX2010010266A (es) * 2008-03-21 2010-12-14 Adlyfe Inc Uso de pireno para llevar peptidos a traves de la barrera hematoencefalica.
NZ589539A (en) * 2008-05-16 2012-08-31 Bioexx Specialty Proteins Ltd Oilseed protein concentrates and isolates, and processes for the production thereof
JP2013006783A (ja) * 2011-06-22 2013-01-10 Nagasaki Univ 荷重感知遺伝子
FI3116521T3 (fi) * 2014-03-14 2024-10-30 Univ New York State Res Found Luun kasvun ja luun rappeutumisen neurogeeninen regulaatio
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
US12344886B2 (en) * 2017-06-15 2025-07-01 Technion Research & Development Foundation Limited Compositions and methods for detection of genomic variations
EP3696192A1 (en) * 2019-02-15 2020-08-19 Consejo Superior De Investigaciones Científicas Therapeutic target and monoclonal antibodies against it for the diagnosis and treatment of alzheimer´s disease

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238839A (en) 1988-02-09 1993-08-24 Dana Farber Cancer Institute Nucleic Acids Encoding proteins which induce immunological effector cell activation and chemattraction, vectors, and recombinant cells
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
CA2117282A1 (en) 1991-11-22 1993-05-27 Ofer Lider Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them
US5578569A (en) 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
US5536814A (en) 1993-09-27 1996-07-16 La Jolla Cancer Research Foundation Integrin-binding peptides
US5726156A (en) 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5846932A (en) 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5632983A (en) 1994-11-17 1997-05-27 University Of South Florida Method for treating secondary immunodeficiency
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
WO1997039357A1 (en) 1996-04-12 1997-10-23 The Board Of Trustees Of The Leland Stanford Junior University Wnt RECEPTOR COMPOSITIONS AND METHODS
US5851984A (en) 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
PT932678E (pt) 1996-09-24 2006-07-31 Tanox Inc Familia de genes que codificam peptidos relacionados com apoptose, peptidos por eles codificados e metodos para sua utilizacao
US5939271A (en) 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
BR9808545A (pt) 1997-04-16 2000-05-23 Amgen Inc ácido nucleico isolado, vetor de expressão, célula hospedeira, processos para produzir uma proteìna de ligação da osteoprotegerina, para detectar a presença de uma proteìna de ligação à osteoprotegerina em uma amostra biológica, para avaliar a capacidade de um composto candidato de ligar-se a uma proteìna de ligação da osteoprotegerina e de um composto de teste para aumentar ou reduzir a ligação da proteìna de ligação da osteoprotegerina a odar, para regular a expressão de uma proteìna de ligação da osteoprotegerina em um animal e para prevenir ou tratar de doença óssea em um mamìfero, polipeptìdeo, protéina de ligação da osteroprotegerina purificada e isolada, ou seu fragmento, análogo ou derivado, e, anticorpo ou seu fragmento
US6043053A (en) 1997-05-23 2000-03-28 Smithkline Beecham Corporation Wnt-3 polynucleotides
AU7704498A (en) 1997-05-29 1998-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Human frp and fragments thereof including methods for using them
EP1012262A4 (en) 1997-08-12 2002-11-06 Human Genome Sciences Inc HFLP PROTEIN HFLP
WO1999026960A2 (en) 1997-11-25 1999-06-03 Millennium Pharmaceuticals, Inc. Genes encoding frizzled-like proteins
WO1999029865A2 (en) 1997-12-12 1999-06-17 The Rockefeller University A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
JPH11196864A (ja) 1998-01-08 1999-07-27 Deinabekku Kenkyusho:Kk 破骨細胞の分化を誘導する方法
US6110718A (en) * 1998-03-20 2000-08-29 Wayne State University Mammalian putative phosphatidylinositol-4-phosphate-5-kinase
WO2001057188A2 (en) 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
AU7131200A (en) 1999-09-13 2001-04-17 Wyeth Pharmaceutical compositions and methods of using secreted frizzled related protein
US6600018B1 (en) * 2000-04-10 2003-07-29 The United States Of America As Represented By The Department Of Health And Human Services Secreted frizzled related protein, sFRP, fragments and methods of use thereof
JP2002181893A (ja) * 2000-12-11 2002-06-26 Mitsubishi Electric Corp 半導体装置の検査方法および検査装置

Similar Documents

Publication Publication Date Title
McConnell et al. Tendamistat as a scaffold for conformationally constrained phage peptide libraries
JP2005501508A5 (enExample)
JP2002521055A5 (enExample)
JP2013539369A5 (enExample)
JP2000312590A5 (enExample)
JP2002518010A5 (enExample)
ITRM940805A1 (it) Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130
Beckendorf Structure of the distal half of the bacteriophage T4 tail fiber
JP2002502589A5 (enExample)
IL142905A (en) Functional antagonists of hedgehog activity
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
CA2323776A1 (en) Cytokine receptor common gamma chain like
CA2302808A1 (en) 50 human secreted proteins
JP2002506625A5 (enExample)
US9708382B2 (en) Peptide library
JP2002517193A5 (enExample)
JP2002533115A5 (enExample)
Fincham et al. Enamel biomineralization: the assembly and disassembly of the protein extracellular organic matrix
JP2009519720A5 (enExample)
Morimoto et al. Synthesis of a large library of macrocyclic peptides containing multiple and diverse N-alkylated residues
JP2004535795A5 (enExample)
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
JP2004500055A5 (enExample)
US7160994B2 (en) Osteoclast-specific genes and proteins and uses thereof
JP2008522632A5 (enExample)